Lord, Abbett & Co’s Acadia Pharmaceuticals ACAD Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-787,028	Closed	-$33.7M	–	625
2019 Q4	$33.7M	Buy	787,028 +170,419	+28%	+$7.41M	0.11%	285
2019 Q3	$22.2M	Buy	+616,609	New	+$18.7M	0.08%	386
2017 Q2	–	Sell	-253,673	Closed	-$8.72M	–	873
2017 Q1	$8.72M	Sell	253,673 -25,800	-9%	-$911K	0.03%	637
2016 Q4	$8.06M	Sell	279,473 -885,811	-76%	-$23.4M	0.02%	631
2016 Q3	$37.1M	Sell	1,165,284 -1,026,169	-47%	-$34.8M	0.11%	286
2016 Q2	$71.1M	Buy	2,191,453 +2,126,453	+3,271%	+$71.2M	0.22%	133
2016 Q1	$1.82M	Sell	65,000 -530,723	-89%	-$11.6M	0.01%	836
2015 Q4	$21.2M	Sell	595,723 -98,506	-14%	-$3.47M	0.06%	412
2015 Q3	$23M	Sell	694,229 -273,869	-28%	-$11.4M	0.07%	382
2015 Q2	$40.5M	Buy	968,098 +584,339	+152%	+$22.6M	0.11%	307
2015 Q1	$12.5M	Sell	383,759 -905,850	-70%	-$31.1M	0.03%	578
2014 Q4	$40.9M	Sell	1,289,609 -488,609	-27%	-$13.9M	0.1%	275
2014 Q3	$44M	Buy	1,778,218 +678,797	+62%	+$15.9M	0.11%	259
2014 Q2	$24.8M	Buy	1,099,421 +200,368	+22%	+$4.18M	0.06%	473
2014 Q1	$21.9M	Sell	899,053 -86,892	-9%	-$2.2M	0.05%	483
2013 Q4	$24.6M	Sell	985,945 -716,073	-42%	-$16.9M	0.05%	473
2013 Q3	$46.8M	Sell	1,702,018 -418,652	-20%	-$8.75M	0.11%	277
2013 Q2	$38.5M	Buy	+2,120,670	New	+$29.2M	0.09%	340